ACHV
HEALTHCAREAchieve Life Sciences Inc
$4.80+0.24 (+5.26%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ACHV Today?
No stock-specific AI insight has been generated for ACHV yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.00$6.03
$4.80
Fundamentals
Market Cap$493M
P/E Ratio—
EPS$-1.25
Dividend Yield—
Dividend / Share—
ROE-2.6%
Profit Margin—
Debt / Equity—
Trading
Volume1.3M
Avg Volume (10D)—
Shares Outstanding102.7M
ACHV News
20 articles- Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026Yahoo Finance·May 5, 2026
- ACHV: Change of Command Brings Material FundingYahoo Finance·Apr 28, 2026
- Achieve Life Sciences Launches Up to $354 Million Private Placement; Names Andrew Goldberg CEO; Shares RiseYahoo Finance·Apr 16, 2026
- Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of DirectorsYahoo Finance·Apr 16, 2026
- Achieve Life Sciences Announces Up to $354 Million Private PlacementYahoo Finance·Apr 16, 2026
- Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma SolutionsYahoo Finance·Apr 15, 2026
- Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable TolerabilityYahoo Finance·Mar 26, 2026
- Achieve Life Sciences, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 25, 2026
- Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ...Yahoo Finance·Mar 24, 2026
- ACHV: 2025 ResultsYahoo Finance·Mar 24, 2026
- Achieve Life Sciences Q4 Earnings Call HighlightsMarketbeat·Mar 24, 2026
- Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesYahoo Finance·Mar 24, 2026
- Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026Yahoo Finance·Mar 17, 2026
- Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL StudyYahoo Finance·Mar 4, 2026
- Achieve Life Sciences, Inc. (ACHV): A Bull Case TheoryYahoo Finance·Feb 3, 2026
- Achieve Life Sciences Announced Granting of New Hire Inducement AwardsYahoo Finance·Jan 30, 2026
- Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near FutureYahoo Finance·Jan 17, 2026
- Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical OfficerYahoo Finance·Jan 12, 2026
- Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference WeekYahoo Finance·Dec 17, 2025
- Institutions profited after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap rose US$48m last week but individual investors profited the mostYahoo Finance·Nov 29, 2025
All 20 articles loaded
Price Data
Open$4.59
Previous Close$4.56
Day High$4.90
Day Low$4.41
52 Week High$6.03
52 Week Low$2.00
52-Week Range
$2.00$6.03
$4.80
Fundamentals
Market Cap$493M
P/E Ratio—
EPS$-1.25
Dividend Yield—
Dividend / Share—
ROE-2.6%
Profit Margin—
Debt / Equity—
Trading
Volume1.3M
Avg Volume (10D)—
Shares Outstanding102.7M
About Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and markets cytisinicline for smoking and nicotine addiction cessation in the United States and internationally. The company is headquartered in Vancouver, Canada.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—